Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor effica

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Davidb Weiner , ,Vaccine Immunotherapy Center ,Wistar Institute ,Wistar Institute Vaccine Immunotherapy Center ,Nature Medicineshow ,Geneos Therapeutics ,Response Evaluation Criteria ,Solid Tumors ,Wistar Institute Vaccine ,Wistar Executive Vice President ,Charitable Trust Distinguished Professor ,Cancer Research ,Newswise ,Eoantigen Vaccine Therapy Liver Cancer Research Hepatocellular Carcinoma Immunologically Cold ,